MAR002 is an early, promising development: a new take on a proven strategy, with the potential for stronger IGF-1 control and dramatically less frequent dosing. At the same time, it’s important to keep expectations grounded. The drug is still investigational. It is not approved, not yet available outside clinical trials, and a larger patient study is needed to confirm what the early data suggest.
From Linda M Rio, PWN contributor and mental health professional – I’m often contacted by those with an already diagnosed pituitary disorder or those who are searching for help and suspect they are impacted but
Dr. Lewis S. Blevins, Jr., M.D., wrote a clear guide to hypopituitarism—what it is, how it’s treated, and why early diagnosis matters in his book, Hypopituitarism.
This excerpt from our presentation on pituitary surgery focuses on surgery in the cavernous sinus and procedure issues, benefits, and risks.
From J D Faccinetti, co-founder – It is often said that once you know people with acromegaly, you will see it more often. It makes you wonder how apt the definition of “rare” is for
Explore why renaming pituitary cysts matters in acromegaly care and how better terms can improve diagnosis and treatment.
We often scan the pituitary universe and report on the latest drug developments, new potential therapies, and engaging clinical cases and resources. We hope this knowledge helps people gain more insight into these complicated diseases and the fascinating medical/scientific discovery, research, and diagnosis world.
Purchase Your Copy Today!
Cushing’s, by Lewis S. Blevins, Jr., MD, communicates ideas regarding this complex disorder that have been attained after years of evaluation and management of patients with hypercortisolism.
Episode 3 of Pituitary Grand Rounds explores cortisol disorders tied to adrenal issues and diagnostic challenges.
There is an urgent world need for people with DI/Vasopressin Deficiency to understand and better manage this condition. The advocacy community, including the World Alliance of Pituitary Organizations – WAPO, the Got DI/AVP patient community,
